Europe Proteomics Market

The Europe proteomics market is projected to reach USD 18.77 billion by 2030 from USD 10.55 billion in 2025, at a CAGR of 12.2%. The growth of the Europe proteomics market is attributed to technological advancements, an aging population, and rising chronic diseases.

Key players in the Europe proteomics market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Qiagen (Netherlands), Agilent Technologies (US), Bruker Corporation (US), Bio-Rad Laboratories (US), Eurofins (Luxembourg), and Protagene (Germany). Companies operating in the market are scaling beyond traditional protein analysis tools into high-throughput, automated platforms, encompassing advanced sample preparation, mass spectrometry, next-generation sequencing-based proteomics, and specialized reagents/kits for complex biologics and multi-omics workflows. By expanding manufacturing capacity and launching integrated hardware-software ecosystems, key players such as Thermo Fisher Scientific and Merck KGaA aim to strengthen their regional dominance in proteome profiling and support precision medicine initiatives spanning drug discovery, translational studies, and diagnostic applications.

To know about the assumptions considered for the study download the pdf brochure

In May 2024, QIAGEN launched a new library preparation kit-QIAseq Multimodal DNA/RNA Library Kit.

 Thermo Fisher Scientific (US)

Thermo Fisher Scientific is a major player in the European proteomics research market. Its expansive range of mass spectrometers, automated systems, and bioinformatics solutions supports its market ranking. Orbitrap-based systems with scalable, end-to-end workflows, as well as artificial intelligence-driven bioinformatics solutions for proteome analysis, have shown synergy with the growing need for standardized, regulated, multi-omics solutions within Europe, making the company a partner of choice for biopharma developers as well as clinical research institutions, especially for precision medicine, biomarker studies, as well as population-scale proteomics.

 Merck KGaA (Germany)

Merck KGaA leads the Europe proteomics market with its robust portfolio of high-performance mass spectrometry systems, advanced chromatography solutions, and integrated bioinformatics platforms, delivering comprehensive insights into protein dynamics and post-translational modifications. By expanding its MilliporeSigma life science offerings with cutting-edge reagent kits and automation tools, the company solidifies its role as a premier partner for academic consortia and biopharma developers advancing multi-omics integration and biomarker validation for next-generation diagnostics.

Qiagen (Netherlands)

Qiagen is a key player in the Europe proteomics market, harnessing its QIAcuity digital PCR systems, advanced sample-to-insight workflows, and robust NGS-compatible kits to provide reliable protein biomarker quantification and multi-omics profiling. Through ongoing enhancements to its Integrated Proteomics for NGS platform and strategic partnerships, the company positions itself as a vital collaborator for translational researchers and clinical labs, accelerating precision oncology and infectious disease proteomics applications.

Market Ranking

Thermo Fisher Scientific roots the European proteomics market with a combination of high-resolution Orbitrap mass spectrometers, Olink-assisted high-plex analyses, and automation-friendly workflows that allow scientists to efficiently transition from raw samples to ready-to-decide proteomic analyses. Merck KGaA roots these workflows with a diverse set of high-quality reagents, antibodies, chromatography Media & Materials, and certified reference materials designed for reproducible, standardized, and ready-to-regulate proteomics analyses. QIAGEN supplements the market ecosystem with enhanced, automation-friendly solutions for proteomic sample preparation and integrated analysis, and seamless access between proteomics analysis results and genomic and transcriptomic analysis results. Agilent Technologies supplements the market ecosystem with integrated LC-MS solutions, enhanced Chromatography solutions, and Spectrum Mill software. Bruker Corporation supplements the market ecosystem with timsTOF high-performance Mass Spectrometers. Bruker emphasizes enhanced-speed proteomic solutions for both large-scale exploration and large-scale analyses.

Related Reports:

Europe Proteomics Market by Instrumentation [Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray], Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery)- Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com